CAPR ALERT: Securities Fraud Class Action Launched Against Capricor Therapeutics, Inc. - September 28, 2026 Deadline
Levi & Korsinsky, LLP announced that a securities class action lawsuit has been filed against Capricor Therapeutics (NASDAQ: CAPR), with a lead plaintiff deadline of September 28, 2026. The complaint covers purchases between December 17, 2025 and July 29, 2026 and alleges defendants concealed that the company changed the pre-specified statistical analysis plan for Deramiocel clinical data without FDA agreement before resubmitting the BLA for Duchenne muscular dystrophy, creating substantial risk to the drug's approval.
Key figures
- Class period end
- July 29, 2026
- Class period start
- December 17, 2025
- Lead plaintiff deadline
- September 28, 2026
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.